US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

REX CRYPTO EQUITY PREMIUM INCOME ETF

31.54

+0.15500.49%

Volume:39.99K

Turnover:1.26M

Market Cap:127.40M

PE:- -

High:31.62

Open:31.58

Low:31.40

Close:31.38

52wk High:43.70

52wk Low:26.98

Shares:4.04M

Float Shares:4.04M

Volume Ratio:1.71

T/O Rate:0.99%

Dividend:13.57

Dividend Rate:43.02%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

US and UK Forge Joint Initiative to Establish Cross-Atlantic Stablecoin Regulatory Framework

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

Press Release: Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Press Release: Samsung Biologics Reports First Quarter 2026 Financial Results

European tissue jumbo roll prices start to rise in March as input cost increases erode margins

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/CEPI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CEPI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","market":"US","secType":"STK","nameCN":"REX CRYPTO EQUITY PREMIUM INCOME ETF","latestPrice":31.535,"timestamp":1791218807170,"preClose":31.38,"halted":0,"volume":39986,"delay":0,"changeRate":0.004939451880178494,"floatShares":4040000,"shares":4040000,"eps":0,"marketStatus":"Trading","change":0.155,"latestTime":"10-05 12:48:25 EDT","open":31.58,"high":31.6231,"low":31.4,"amount":1260004.324082,"amplitude":0.00711,"askPrice":31.62,"askSize":100,"bidPrice":31.46,"bidSize":5,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":31.38,"sharesOutstanding":2715000,"nav":31.01,"aum":123729900,"dividendRate":0.430236,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":31.5394,"preClose":31.38,"latestTime":"09:22 EDT","volume":3882,"amount":121720.27692599999,"timestamp":1791206568229,"change":0.1594,"changeRate":0.00508,"amplitude":0.025494},"postHourTrading":{"tag":"盘后","latestPrice":31.48,"preClose":31.38,"latestTime":"19:48 EDT","volume":4105,"amount":129109.23,"timestamp":1790984908661,"change":0.1,"changeRate":0.003187,"amplitude":0.003187},"volumeRatio":1.706708,"impliedVol":0.0494,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","floatShares":4040000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.706708,"shares":4040000,"dividePrice":13.5675,"high":31.6231,"amplitude":0.00711,"preClose":31.38,"low":31.4,"week52Low":26.981,"pbRate":"--","week52High":43.7,"institutionHeld":0,"latestPrice":31.535,"committee":-0.904762,"eps":0,"divideRate":0.430236,"volume":39986,"delay":0,"ttmEps":0,"open":31.58,"prevYearClose":33.6685,"prevWeekClose":31.38,"prevMonthClose":30.9566,"prevQuarterClose":30.9566,"fiveDayClose":31.4618,"twentyDayClose":31.81,"sixtyDayClose":32.7651},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEPI\",params:#limit:5,,,undefined,":[{"date":"2026-09-30","symbol":"CEPI","amount":0.253308,"announcedDate":"2026-09-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-30","defaultRemindTime":1790775000000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-01","payableDate":"2026-09-30","currency":"USD","dateTimestamp":1790740800000,"payDate":"2026-10-01"},{"date":"2026-09-23","symbol":"CEPI","amount":0.259853,"announcedDate":"2026-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-23","defaultRemindTime":1790170200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-24","payableDate":"2026-09-23","currency":"USD","dateTimestamp":1790136000000,"payDate":"2026-09-24"},{"date":"2026-09-16","symbol":"CEPI","amount":0.251289,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-17","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-17"},{"date":"2026-09-09","symbol":"CEPI","amount":0.2567,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-09","defaultRemindTime":1788960600000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-10","payableDate":"2026-09-09","currency":"USD","dateTimestamp":1788926400000,"payDate":"2026-09-10"},{"date":"2026-09-02","symbol":"CEPI","amount":0.25153,"announcedDate":"2026-09-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-02","defaultRemindTime":1788355800000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-03","payableDate":"2026-09-02","currency":"USD","dateTimestamp":1788321600000,"payDate":"2026-09-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEPI\",market:\"US\",,,undefined,":[{"executeDate":"2025-01-28","recordDate":"2025-01-28","paymentDate":"2025-01-29","value":1.69835,"currency":"USD"},{"executeDate":"2025-02-25","recordDate":"2025-02-25","paymentDate":"2025-02-26","value":1.57775,"currency":"USD"},{"executeDate":"2025-03-25","recordDate":"2025-03-25","paymentDate":"2025-03-26","value":1.45915,"currency":"USD"},{"executeDate":"2025-04-29","recordDate":"2025-04-29","paymentDate":"2025-04-30","value":1.3286,"currency":"USD"},{"executeDate":"2025-05-29","recordDate":"2025-05-29","paymentDate":"2025-05-30","value":1.3881,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEPI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CEPI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1144854279","title":"US and UK Forge Joint Initiative to Establish Cross-Atlantic Stablecoin Regulatory Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1144854279","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144854279?lang=en_us&edition=fundamental","pubTime":"2026-07-15 03:42","pubTimestamp":1784058157,"startTime":"0","endTime":"0","summary":"In a significant move, the United States and the United Kingdom are collaborating to establish a cross-Atlantic regulatory framework for stablecoins, aiming to promote the broader adoption of these...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTCL","XBTY","BITO","MNRS","CONX","YBTC","SETH","BTCZ","QETH","CBTJ","BITB","ETHW","UDN","EZET","DECO","QBF","ARKB","ETQ","IBIT","BLCN","ICOI","BTF","COIW","BRRR","EZBC","FBTC","YETH","CBOY","UUP","ETHT","BETE","CBTA","CEPI","DEFI","ARKC","SBIT","FIAT","BITX","TETH","ETHV","DFII","ETHD","CBXJ","BFAP","ETCO","ARKZ","IBLC","ESK","EETH","BCDF","CBXY","SATO","ETU","CBOJ","XTRKF","FTGPF","ETH","LEGR","COYY","BITU","CBXA","MAXI","BPI","BTCW","CONI","ETHI","BTC","COII","GBTC","BFJL","ETHA","CBOO","CONY","BTCI","BCCC","ETHU","LMBO","BETH","BTRN","CBTY","BTCO","BAGY","CBTO","COIG","ETHE","BITY","FETH","COIO","HODL","BITI","FDIG","CONL","CBXO","BLKC","CBOA","GENZ","BTFX","BTCC","COIA","FDFF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649531982","title":"Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2649531982","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649531982?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:25","pubTimestamp":1783423500,"startTime":"0","endTime":"0","summary":"C1 Monoclonal Antibody Progress for RSV and Malaria Following Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla., July  07, 2026  (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/07/3323055/0/en/Global-Collaborations-Continue-to-Validate-Dyadic-s-C1-Platform-and-Expands-Commercial-Potential.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEPI","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635444279","title":"Press Release: Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635444279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635444279?lang=en_us&edition=fundamental","pubTime":"2026-05-13 13:00","pubTimestamp":1778648400,"startTime":"0","endTime":"0","summary":"-- Cash position of EUR105.3 million as of end March 2026, excluding. proceeds from successful reserved offering completed in April 20261. -- Program launched in April to further reduce operating expenses. -- Pfizer expected to file regulatory submissions for Lyme disease vaccine. Lyon , May 13, 2026 -- Valneva SE , a specialty vaccine company, today reported its financial results for the first quarter ended March 31, 2026, provided key corporate updates, and updated its 2026 financial guidance. The condensed consolidated interim financial results are available on the Company's website .Valneva will provide a live webcast of its first quarter 2026 results conference call beginning. -- Total revenues were EUR30.9 million, including EUR30.5 million in product. sales, compared with EUR49.2 million and EUR48.6 million, respectively,in the first quarter of 2025, mainly reflecting the planned wind-down of. different shipment phasing to the U.S. Department of Defense. the first quarter of 202","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4539","BK4232","VALN","BK4139","BK4022","CEPI","CHIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629319097","title":"Press Release: Samsung Biologics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2629319097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629319097?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:50","pubTimestamp":1776840600,"startTime":"0","endTime":"0","summary":"-- Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW. -- Performance driven by full utilization across Plants 1 through 4 and. INCHEON, South Korea, April 22, 2026 /PRNewswire/ -- Samsung Biologics , a leading contract development and manufacturing organization , reported financial results for the first quarter of fiscal year 2026.In March, Samsung Biologics completed the acquisition of its Rockville manufacturing facility in Maryland, U.S. for USD 353 million, establishing its first U.S. manufacturing presence and further strengthening client proximity and supply chain resilience in a key market. Samsung Biologics also continues to evaluate strategic investments to further diversify its manufacturing network and support clients seeking regional supply alignment amid an evolving global operating env","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","03160","BK4585","BK4555","IEMG","BK4550","BK4604","TM","CDMO","CEPI","BK4099","BK4581","BK4504","EMXC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627741409","title":"European tissue jumbo roll prices start to rise in March as input cost increases erode margins","url":"https://stock-news.laohu8.com/highlight/detail?id=2627741409","media":"Fastmarkets","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627741409?lang=en_us&edition=fundamental","pubTime":"2026-04-14 12:00","pubTimestamp":1776139200,"startTime":"0","endTime":"0","summary":"Producers are announcing price hikes of up to €100 per tonne to offset soaring input costs, with further increases expected from April. Learn more.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fastmarkets_highlight","url":"https://www.fastmarkets.com/insights/european-tissue-jumbo-roll-prices-start-to-rise-in-march-as-input-cost-increases-erode-margins/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fastmarkets.com/insights/european-tissue-jumbo-roll-prices-start-to-rise-in-march-as-input-cost-increases-erode-margins/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fastmarkets_highlight","symbols":["CEPI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":25,"code":"91000000","status":"200"}]}}